The combined repetitive oligopeptides (CROPs) of Clostridium difficile toxins A (TcdA) and B (TcdB) induce clathrin-mediated endocytosis of the toxins. Inconsistently, CROP-truncated TcdA1–1874 is also capable of entering host cells and displaying full cytotoxic properties although with less potency. Pre-incubation of cells with isolated CROPs, however, reconstitutes the reduced uptake of TcdA1–1874 to the level of the full-length toxin. We believe that TcdA exhibits an additional binding motif beyond the C-terminally located CROP domain, which might interact with cellular receptor structures that are associated with alternative internalization pathways. This study therefore evaluated endocytosis routes of CROP-dependent cellular uptake for TcdA and CROP-independent cellular uptake for TcdA1–1874. Clathrin knockdown or inhibition with chlorpromazine affected subsequent internalization of TcdA and TcdA1–1874, although only to some extent, arguing for alternative, clathrin-independent endocytosis routes. Inhibition of dynamin, a GTPase essentially involved in clathrin-mediated endocytosis as well as in various clathrin-independent uptake mechanisms, affected uptake of TcdA to the same extent as clathrin inhibition. In contrast, uptake of TcdA1–1874 was almost completely eliminated in dynamin-inhibited cells. Thus, clathrin-independent uptake of TcdA1–1874 presumably depends on dynamin. These findings demonstrate that the toxins are endocytosed via complex pathways involving clathrin and dynamin, putatively enabling them to adapt to mechanisms of various cell types. With regard to the emergence of C. difficile strains producing C-terminally truncated toxins, this study emphasizes the relevance of elucidating toxin uptake as a prerequisite for the development of toxin intervention strategies.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
AmimotoK.,
NoroT.,
OishiE.,
ShimizuM.2007; A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology 153:1198–1206 [View Article][PubMed]
BroeckD. V.,
LagrouA. R.,
De WolfM. J.2007; Distinct role of clathrin-mediated endocytosis in the functional uptake of cholera toxin. Acta Biochim Pol 54:757–767[PubMed]
BurgerS.,
TatgeH.,
HofmannF.,
GenthH.,
JustI.,
GerhardR.2003; Expression of recombinant Clostridium difficile toxin A using the Bacillusmegaterium system. Biochem Biophys Res Commun 307:584–588 [View Article][PubMed]
FrischC.,
GerhardR.,
AktoriesK.,
HofmannF.,
JustI.2003; The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem Biophys Res Commun 300:706–711 [View Article][PubMed]
HidalgoI. J.,
RaubT. J.,
BorchardtR. T.1989; Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736–749[PubMed]
HuetC.,
Sahuquillo-MerinoC.,
CoudrierE.,
LouvardD.1987; Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol 105:345–357 [View Article][PubMed]
JankT.,
AktoriesK.2008; Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol 16:222–229 [View Article][PubMed]
KeelM. K.,
SongerJ. G.2007; The distribution and density of Clostridiumdifficile toxin receptors on the intestinal mucosa of neonatal pigs. Vet Pathol 44:814–822 [View Article][PubMed]
MirreC.,
MonlauzeurL.,
GarciaM.,
DelgrossiM. H.,
Le BivicA.1996; Detergent-resistant membrane microdomains from Caco-2 cells do not contain caveolin. Am J Physiol 271:C887–C894[PubMed]
OllingA.,
GoyS.,
HoffmannF.,
TatgeH.,
JustI.,
GerhardR.2011; The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PLoS ONE 6:e17623 [View Article][PubMed]
PruittR. N.,
LacyD. B.2012; Toward a structural understanding of Clostridium difficile toxins A and B. Front Cell Infect Microbiol 2:28 [View Article][PubMed]
StubbeH.,
BerdozJ.,
KraehenbuhlJ.-P.,
CorthésyB.2000; Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 164:1952–1960[PubMed][CrossRef]
van den BergR. J.,
ClaasE. C.,
OyibD. H.,
KlaassenC. H. W.,
DijkshoornL.,
BrazierJ. S.,
KuijperE. J.2004; Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 42:1035–1041 [View Article][PubMed]
von Eichel-StreiberC.,
Laufenberg-FeldmannR.,
SartingenS.,
SchulzeJ.,
SauerbornM.1992; Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 233:260–268 [View Article][PubMed]